Furthermore, mutations in the IDH1 gene [45], as well as depletion of histone chaperone ASF1 [46], have been implicated in the activation of the ALT phenotype, indicating that ALT activation in tumor cells is not solely dependent on ATRX/H3-3A mutations. The gene discussed is ATRX; the disease is neoplasm.